Home / Health / Obesity Drug Patient Reclaims Life: Beyond the Needle
Obesity Drug Patient Reclaims Life: Beyond the Needle
20 Mar
Summary
- Patient started Mounjaro at 119 kg, now aims for 85 kg.
- Weight loss drug mimics hormones to regulate appetite and slow digestion.
- Lifestyle changes are crucial for sustained weight management post-drug.
Pranav Gupta, a 44-year-old from Prayagraj, has significantly transformed his health by losing 25 kg since beginning a Mounjaro treatment in June of last year. Starting at 119 kg, he now weighs 94 kg and aims to reach 85 kg, viewing the medication as a catalyst rather than a permanent solution. Gupta's journey highlights a renewed focus on exercise, meal discipline, and adequate sleep, essential components for long-term well-being.
Dr. Subhash Wangnoo from Apollo Centre for Obesity explains that obesity is a complex, chronic disease influenced by genetics, environment, and metabolism, not just willpower. He prescribed Mounjaro, an injectable medication with tirzepatide, for Gupta. This drug mimics hormones GLP-1 and GIP, regulating appetite and slowing digestion, leading to substantial weight loss.
Gupta's health had deteriorated due to diabetes and obesity, compounded by a severe road accident and subsequent inactivity during the COVID-19 pandemic. A bacterial skin infection in 2024, leading to hospitalization, served as a critical wake-up call. His blood sugar levels were dangerously high, necessitating high-dose insulin shots.
After initiating Mounjaro in June of last year, Gupta experienced side effects like changes in taste, constipation, and nausea, which eventually subsided. By September 2025, his health markers improved dramatically: fasting blood sugar dropped to 102 mg/dL and HbA1c to 5.4. His sleep apnea also improved, reducing his reliance on a C-PAP machine.
Dr. Wangnoo stresses that medication efficacy is amplified when paired with rigorous lifestyle corrections in diet, exercise, and sleep. He warns that discontinuing medication often leads to weight regain and the resurfacing of health risks. Gupta adheres to a structured meal plan and an hour of daily physiotherapy, regaining mobility and confidence.
Concerns are raised about the social media hype surrounding these prescription drugs and the proliferation of generics without adequate medical supervision. Dr. Wangnoo emphasizes the necessity of comprehensive screening, gradual dose escalation, and ongoing medical oversight to ensure patient safety and pharmacovigilance, especially as patents expire.
